Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
暂无分享,去创建一个
S. Balaji | Mohamed M. Ali | Abeer M. Mahmoud | Imaduddin Mirza | Mohammed Morsy | A. Antony | Hania Deen | Harry Tonchev | Giorgia Scichilone
[1] D. Marković,et al. Interplay between stress and cancer—A focus on inflammation , 2023, Frontiers in Physiology.
[2] K. Visvanathan,et al. Lifestyle factors in Black female breast cancer survivors—Descriptive results from an online pilot study , 2023, Frontiers in Public Health.
[3] P. Arveux,et al. Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer , 2023, JAMA network open.
[4] S. Zarich,et al. Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S. , 2023, JACC. CardioOncology.
[5] C. Ambrosone,et al. Association of Cigarette Smoking and Alcohol Consumption With Subsequent Mortality Among Black Breast Cancer Survivors in New Jersey , 2023, JAMA network open.
[6] Nila A. Sathe,et al. Racial Health Equity and Social Needs Interventions , 2023, JAMA network open.
[7] D. Miketinas,et al. Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011–2018 , 2022, Scientific Reports.
[8] R. Altena,et al. Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies , 2022, Cancers.
[9] G. Boriani,et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal.
[10] S. Virani,et al. Racial/Ethnic Disparities and Determinants of Sufficient Physical Activity Levels , 2022, Kansas journal of medicine.
[11] Yang Li,et al. Can Dietary Nutrients Prevent Cancer Chemotherapy-Induced Cardiotoxicity? An Evidence Mapping of Human Studies and Animal Models , 2022, Frontiers in Cardiovascular Medicine.
[12] Chang Xu,et al. Risk Factors for Anthracycline-Induced Cardiotoxicity in Breast Cancer Treatment: A Meta-Analysis , 2022, Frontiers in Oncology.
[13] Fàtima Rodríguez,et al. Unique Cardiovascular Disease Risk Factors in Hispanic Individuals , 2022, Current Cardiovascular Risk Reports.
[14] C. Ndumele,et al. Disparities in Health Care Spending and Utilization Among Black and White Medicaid Enrollees , 2022, JAMA health forum.
[15] M. Kerin,et al. Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review , 2022, BMC cancer.
[16] T. Marwick. Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment , 2022, Current Oncology Reports.
[17] W. Demark-Wahnefried,et al. Examining the Association of Food Insecurity and Being Up-To-Date for Breast and Colorectal Cancer Screenings. , 2022, Cancer Epidemiology, Biomarkers and Prevention.
[18] Ziqiang Yang,et al. Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect , 2022, Frontiers in Pharmacology.
[19] S. Thotamgari,et al. Racial Disparities in Cardiovascular Disease Among Patients with Cancer in the United States: The Elephant in the Room , 2022, EClinicalMedicine.
[20] Y. Arbel,et al. Prevalence of Right Ventricle Strain Changes following Anthracycline Therapy , 2022, Life.
[21] D. Berrigan,et al. Structural Racism and Triple-Negative Breast Cancer Among Black and White Women in the United States , 2022, Health equity.
[22] Melissa L. Abel,et al. Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes , 2021, Journal of the American Heart Association.
[23] W. Knowler,et al. Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study , 2021, Lancet Regional Health. Americas.
[24] L. Cousin,et al. Cardio-Oncology Health Disparities: Social Determinants of Health and Care for Black Breast Cancer Survivors. , 2021, Clinical journal of oncology nursing.
[25] Guodong Yang,et al. Risk Factors for Anthracycline-Induced Cardiotoxicity , 2021, Frontiers in Cardiovascular Medicine.
[26] S. Wong,et al. Reporting on Race and Racial Disparities in Breast Cancer , 2021, Annals of surgery.
[27] Laney K. Jones,et al. Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia , 2021, Journal of the American Heart Association.
[28] K. Murugiah,et al. Trends in Differences in Health Status and Health Care Access and Affordability by Race and Ethnicity in the United States, 1999-2018. , 2021, JAMA.
[29] S. Bleich,et al. Disparities in Adult Fast-Food Consumption in the U.S. by Race and Ethnicity, National Health and Nutrition Examination Survey 2017-2018. , 2021, American journal of preventive medicine.
[30] T. Brown,et al. Structural Intersectionality as a New Direction for Health Disparities Research , 2021, Journal of health and social behavior.
[31] J. Leonard,et al. An Assessment of Race as a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B-Cell Lymphoma. , 2021, Clinical lymphoma, myeloma & leukemia.
[32] A. Dhir,et al. Cardiac morbidity & mortality in patients with breast cancer: A review , 2021, The Indian journal of medical research.
[33] E. Rutgers,et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] Yuelin Li,et al. The association between housing and food insecurity among medically underserved cancer patients , 2021, Supportive Care in Cancer.
[35] J. Scalici,et al. Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers , 2021, International Journal of Gynecological Cancer.
[36] A. Narezkina,et al. Molecular mechanisms of anthracycline cardiovascular toxicity. , 2021, Clinical science.
[37] Huiqin Guo,et al. Whole grain cereals: the potential roles of functional components in human health , 2021, Critical reviews in food science and nutrition.
[38] G. Lamas,et al. Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met , 2021, Journal of the American Heart Association.
[39] D. Lizotte,et al. Intersectionality in quantitative research: A systematic review of its emergence and applications of theory and methods , 2021, SSM - population health.
[40] Arjun K. Ghosh,et al. BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab , 2021, JACC. CardioOncology.
[41] J. Tobin,et al. Racial and Socioeconomic Disparities in Cardiotoxicity among Women with HER2-Positive Breast Cancer. , 2021, The American journal of cardiology.
[42] Ken R. Smith,et al. Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort , 2021, JNCI cancer spectrum.
[43] A. Ghigo,et al. Metabolic Aspects of Anthracycline Cardiotoxicity , 2021, Current Treatment Options in Oncology.
[44] P. Thavendiranathan,et al. Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies , 2021, Oxidative medicine and cellular longevity.
[45] C. Ballantyne,et al. Ten things to know about ten cardiovascular disease risk factors , 2021, American journal of preventive cardiology.
[46] W. Al-Delaimy,et al. Minority Representation in Clinical Trials in the United States: Trends Over the Past 25 Years. , 2021, Mayo Clinic proceedings.
[47] E. John,et al. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[48] D. Kalra. Bridging the Racial Disparity Gap in Lipid‐Lowering Therapy , 2020, Journal of the American Heart Association.
[49] Samy I McFarlane,et al. Incidence and Associated Risk Factors of Chemotherapy-Induced Cardiomyopathy in the African American and Afro-Caribbean Populations , 2020, International journal of clinical research & trials.
[50] Jennifer E Liu,et al. Strain Imaging in Cardio-Oncology , 2020, JACC. CardioOncology.
[51] S. Bhatia. Genetics of Anthracycline Cardiomyopathy in Cancer Survivors , 2020, JACC. CardioOncology.
[52] F. Asselbergs,et al. Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy , 2020, Cardio-Oncology.
[53] B. Trachtenberg,et al. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity , 2020, Cardio-Oncology.
[54] Dwight E Heron,et al. A Multi-faceted Intervention Aimed at Black-White Disparities in the Treatment of Early Stage Cancers: The ACCURE Pragmatic Quality Improvement trial. , 2020, Journal of the National Medical Association.
[55] Melissa B. Davis,et al. Cancer health disparities in racial/ethnic minorities in the United States , 2020, British Journal of Cancer.
[56] M. Rizzo,et al. Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors. , 2020, Metabolism: clinical and experimental.
[57] A. Vaitiekiene,et al. HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity , 2020, Cardiovascular Toxicology.
[58] P. Fagan,et al. Widening disparities in cigarette smoking by race/ethnicity across education level in the United States. , 2020, Preventive medicine.
[59] J. Sparano,et al. The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression , 2020, Frontiers in Oncology.
[60] A. Cudnoch-Jędrzejewska,et al. Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications , 2020, Heart Failure Reviews.
[61] L. Keister,et al. Beyond Net Worth: Racial Differences in Wealth Portfolios and Black–White Health Inequality across the Life Course , 2020, Journal of health and social behavior.
[62] Jeroen J. Bax,et al. Global longitudinal strain: clinical use and prognostic implications in contemporary practice , 2020, Heart.
[63] D. Leroith,et al. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women , 2020, Breast Cancer Research.
[64] Anna María Nápoles,et al. COVID-19 and Racial/Ethnic Disparities. , 2020, JAMA.
[65] L. Farahmand,et al. Breast cancer: Biology, biomarkers, and treatments. , 2020, International immunopharmacology.
[66] K. Bibbins-Domingo,et al. This Time Must Be Different: Disparities During the COVID-19 Pandemic , 2020, Annals of Internal Medicine.
[67] M. Marino,et al. The Affordable Care Act improved health insurance coverage and cardiovascular‐related screening rates for cancer survivors seen in community health centers , 2020, Cancer.
[68] C. Cipolla,et al. Cardiotoxicity of Anthracyclines , 2020, Frontiers in Cardiovascular Medicine.
[69] B. Beech,et al. The Association between Hypertension and Race/Ethnicity among Breast Cancer Survivors , 2020, Journal of Racial and Ethnic Health Disparities.
[70] A. Azami,et al. Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats. , 2020, Archives of Razi Institute.
[71] Jennifer E Liu. Anthracycline-Induced Cardiotoxicity , 2020, JACC. CardioOncology.
[72] A. Barac,et al. Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity. , 2020, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[73] Jinyi Lin,et al. Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography , 2020, JACC. CardioOncology.
[74] L. Cai,et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence , 2020, Nature Reviews Cardiology.
[75] B. Jensen,et al. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2–mediated activation of forkhead box O1 , 2020, The Journal of Biological Chemistry.
[76] L. Collin,et al. A balancing act: racial disparities in cardiovascular disease mortality among women diagnosed with breast cancer. , 2020, Annals of cancer epidemiology.
[77] F. André,et al. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study , 2019, PLoS medicine.
[78] L. Collin,et al. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. , 2019, International journal of epidemiology.
[79] A. Vaitiekiene,et al. Impact of Arterial Hypertension on Doxorubicin-Based Chemotherapy-Induced Subclinical Cardiac Damage in Breast Cancer Patients , 2019, Cardiovascular Toxicology.
[80] H. Borno,et al. Food insecurity screening: A missing piece in cancer management , 2019, Cancer.
[81] L. Ellis,et al. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018. , 2019, JAMA oncology.
[82] F. Gany,et al. "You Have to Keep a Roof Over Your Head": A Qualitative Study of Housing Needs Among Patients With Cancer in New York City. , 2019, Journal of oncology practice.
[83] S. Coughlin. Social determinants of breast cancer risk, stage, and survival , 2019, Breast Cancer Research and Treatment.
[84] M. Flint,et al. Stress and drug resistance in cancer , 2019, Cancer drug resistance.
[85] I. Kenessey,et al. Risk prediction model for long-term heart failure incidence after epirubicin chemotherapy for breast cancer - A real-world data-based, nationwide classification analysis. , 2019, International journal of cardiology.
[86] E. Biskup,et al. Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment , 2019, Molecular and clinical oncology.
[87] T. Spruill,et al. Why Are Young Black Women at High Risk for Cardiovascular Disease? , 2019, Circulation.
[88] In Hye Lee,et al. Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway , 2019, Laboratory Investigation.
[89] Eric P. Winer,et al. Breast Cancer Treatment: A Review , 2019, JAMA.
[90] A. Kostic,et al. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States , 2018, Diabetes/metabolism research and reviews.
[91] G. Mensah. Cardiovascular Diseases in African Americans: Fostering Community Partnerships to Stem the Tide. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[92] W. Hundley,et al. When Left Ventricular Extracellular Volume Fraction Changes After Anthracyclines: Is it Due to a Change in the Numerator, Denominator, or Both? , 2018, JACC. Cardiovascular imaging.
[93] W. Leisenring,et al. Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. , 2018, Blood advances.
[94] R. Masetti,et al. Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer. , 2018, European review for medical and pharmacological sciences.
[95] Lawrence H Kushi,et al. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study , 2018, Journal of Cancer Survivorship.
[96] M. Gulati,et al. The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease , 2018, Clinical cardiology.
[97] P. Henriksen,et al. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention , 2017, Heart.
[98] C. Yancy,et al. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association , 2017, Circulation.
[99] S. Gehlert,et al. Black-White Disparities in Breast Cancer Subtype: The Intersection of Socially Patterned Stress and Genetic Expression , 2017, AIMS public health.
[100] D. Serie,et al. Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial , 2017, Pharmacogenetics and genomics.
[101] Jing Zhong,et al. Triple-negative breast cancer and its association with obesity. , 2017, Molecular and clinical oncology.
[102] K. Ferdinand,et al. Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence , 2017, Journal of clinical hypertension.
[103] A. Olshan,et al. Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study , 2017, Cancer Causes & Control.
[104] D. Roden,et al. Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults , 2017, Pharmacogenetics and genomics.
[105] D. Goff,et al. Cardiovascular Mortality Differences-Place Matters. , 2017, JAMA.
[106] P. Tchounwou,et al. Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States , 2017, International journal of environmental research and public health.
[107] T. Marwick,et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study , 2017, PloS one.
[108] A. Jemal,et al. Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950–2014: Over Six Decades of Changing Patterns and Widening Inequalities , 2017, Journal of environmental and public health.
[109] W. Guo,et al. Hypertension and breast cancer risk: a systematic review and meta-analysis , 2017, Scientific Reports.
[110] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[111] M. Scherrer-Crosbie,et al. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice. , 2017, Antioxidants & redox signaling.
[112] D. Berrigan,et al. Racial and Ethnic Differences in Dietary Intake, Physical Activity, and Body Mass Index (BMI) Among Cancer Survivors: 2005 and 2010 National Health Interview Surveys (NHIS) , 2017, Journal of Racial and Ethnic Health Disparities.
[113] C. Moy,et al. Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults , 2017, Journal of the American Geriatrics Society.
[114] D. Pennell,et al. Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer , 2016, PloS one.
[115] N. Limdi,et al. US Mortality: Influence of Race, Geography and Cardiovascular Risk Among Participants in the Population-Based REGARDS Cohort , 2016, Journal of Racial and Ethnic Health Disparities.
[116] L. Rochette,et al. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[117] L. Badano,et al. The use of multimodality cardiovascular imaging to assess right ventricular size and function. , 2016, International journal of cardiology.
[118] X. Shu,et al. Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography , 2016, Scientific Reports.
[119] W. Johnson,et al. Intimate Partner Violence Among Women Diagnosed With Cancer , 2016, Cancer nursing.
[120] N. Gordon,et al. Obesity Severity, Dietary Behaviors, and Lifestyle Risks Vary by Race/Ethnicity and Age in a Northern California Cohort of Children with Obesity , 2016, Journal of obesity.
[121] Bonnie Ky,et al. Cancer Therapy–Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging , 2016, Circulation. Heart failure.
[122] A. Neugut,et al. Cardiovascular Disease Mortality Among Breast Cancer Survivors , 2016, Epidemiology.
[123] D. Farhud. Impact of Lifestyle on Health , 2015, Iranian journal of public health.
[124] G. Karimi,et al. Arsenic cardiotoxicity: An overview. , 2015, Environmental toxicology and pharmacology.
[125] G. Filippatos,et al. Risk of Heart Failure and Death After Prolonged Smoking CessationCLINICAL PERSPECTIVE , 2015 .
[126] Amy R. Peck,et al. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism , 2015, Oncogene.
[127] G. Curigliano,et al. Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy , 2015, Circulation.
[128] P. Neven,et al. Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients , 2015, Breast Cancer Research and Treatment.
[129] Kevin A. Henry,et al. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.
[130] L. Newman. Disparities in Breast Cancer and African Ancestry: A Global Perspective , 2015, The breast journal.
[131] Kevin C Oeffinger,et al. Individual prediction of heart failure among childhood cancer survivors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[132] A. Trentham-Dietz,et al. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast , 2014, Breast Cancer Research and Treatment.
[133] Cecile M. Farnum,et al. The Intersection between Food Insecurity and Diabetes: A Review , 2014, Current Nutrition Reports.
[134] I. Piña,et al. Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association , 2014, Circulation.
[135] J. Coresh,et al. Trends in Prevalence and Control of Diabetes in the United States, 19881994 and 19992010 , 2014, Annals of Internal Medicine.
[136] P. Fumoleau,et al. Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials. , 2014, European journal of cancer.
[137] Li Zhao,et al. XRCC1 Arg399Gln Polymorphism Confers Risk of Breast Cancer in American Population: A Meta-Analysis of 10846 Cases and 11723 Controls , 2014, PloS one.
[138] M. Hayden,et al. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children , 2013, Pediatric blood & cancer.
[139] R. Ness,et al. Racial variation in toll-like receptor variants among women with pelvic inflammatory disease. , 2013, The Journal of infectious diseases.
[140] M. Hayden,et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[141] M. Siahpush,et al. Socioeconomic, Rural-Urban, and Racial Inequalities in US Cancer Mortality: Part I—All Cancers and Lung Cancer and Part II—Colorectal, Prostate, Breast, and Cervical Cancers , 2012, Journal of cancer epidemiology.
[142] Andrea López,et al. Food Insecurity and Glycemic Control Among Low-Income Patients With Type 2 Diabetes , 2012, Diabetes Care.
[143] K. Pollack,et al. Place, Not Race: Disparities Dissipate In Southwest Baltimore When Blacks And Whites Live Under Similar Conditions , 2011 .
[144] Pál Pacher,et al. Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. , 2011, Circulation.
[145] S. Geller,et al. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress? , 2011, Journal of women's health.
[146] M. Soresi,et al. IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. , 2011, Omics : a journal of integrative biology.
[147] D. Sorkin,et al. Racial/Ethnic Disparities in Exercise and Dietary Behaviors of Middle-Aged and Older Adults , 2010, Journal of General Internal Medicine.
[148] D. Sawyer,et al. Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage , 2010, Current hypertension reports.
[149] V. Cornelius,et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials , 2010, BMC Cancer.
[150] R. Kloner,et al. Particulate air pollution and coronary heart disease , 2009, Current opinion in cardiology.
[151] Richard A. Williams. Cardiovascular disease in African American women: a health care disparities issue. , 2009, Journal of the National Medical Association.
[152] R. Gray,et al. Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer. , 2009, Cancer research.
[153] U. Manne,et al. Prognostic Significance of p53 Codon 72 Polymorphism Differs with Race in Colorectal Adenocarcinoma , 2009, Clinical Cancer Research.
[154] L. Esserman,et al. Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients , 2009, International journal of cancer.
[155] D. Bowen,et al. Race/Ethnicity, Physical Activity, and Quality of Life in Breast Cancer Survivors , 2009, Cancer Epidemiology Biomarkers & Prevention.
[156] H. Chung,et al. XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. , 2008, Gynecologic oncology.
[157] H. Mehendale,et al. High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity. , 2008, Toxicology and applied pharmacology.
[158] J. Rotter,et al. Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study. , 2008, American journal of hypertension.
[159] Päivi Heikkilä,et al. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer , 2008, Nature Genetics.
[160] Lauren Hale,et al. Neighborhood socioeconomic status and fruit and vegetable intake among whites, blacks, and Mexican Americans in the United States. , 2008, The American journal of clinical nutrition.
[161] K. Kyriacou,et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus , 2008, Breast Cancer Research and Treatment.
[162] Laurence Zitvogel,et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.
[163] L. Newman,et al. Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: the need for more genetic epidemiology. , 2007, The Surgical clinics of North America.
[164] R. Lafrenie,et al. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[165] S. Geller,et al. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. , 2006, Journal of women's health.
[166] Yuntao Xie,et al. p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer , 2005, Clinical Cancer Research.
[167] Mi Ae Kim,et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype , 2005, Oncogene.
[168] P. Ganz,et al. Obesity and Cardiovascular Risk Factors in Younger Breast Cancer Survivors: The Cancer and Menopause Study (CAMS) , 2005, Breast Cancer Research and Treatment.
[169] J. Kark,et al. Doxorubicin cardiotoxicity in African Americans. , 2004, Journal of the National Medical Association.
[170] S. Swain,et al. Congestive heart failure in patients treated with doxorubicin , 2003, Cancer.
[171] Heinrich Taegtmeyer,et al. Obesity and the risk of heart failure. , 2002, The New England journal of medicine.
[172] D. Harlan,et al. Ethnicity Greatly Influences Cytokine Gene Polymorphism Distribution , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[173] D. Ross,et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. , 2001, Molecular pharmacology.
[174] G. Martinelli,et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. , 2000, Journal of the American College of Cardiology.
[175] P. Mitchell,et al. Estimates of animal and plant protein intake in US adults: results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1999, Journal of the American Dietetic Association.
[176] Miranda Thomas,et al. Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically , 1999, Molecular and Cellular Biology.
[177] M. Nachman,et al. DNA variability and recombination rates at X-linked loci in humans. , 1998, Genetics.
[178] P. Singal,et al. Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.
[179] S. Gapstur,et al. Hormone receptor status of breast tumors in black, Hispanic, and non‐Hispanic white women: An analysis of 13,239 cases , 1996, Cancer.
[180] J. Doroshow. Doxorubicin-induced cardiac toxicity. , 1991, The New England journal of medicine.
[181] D. Lehotay,et al. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity. , 1982, Cancer treatment reports.
[182] E. Argulian,et al. Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012 , 2017, Circulation. Cardiovascular quality and outcomes.
[183] J. Benítez,et al. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients , 2017, Breast Cancer Research and Treatment.
[184] Aamir Ahmad,et al. Biological basis of cancer health disparities: resources and challenges for research. , 2017, American journal of cancer research.
[185] M. Florescu,et al. Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer , 2017, American journal of therapeutics.
[186] David J Lee,et al. Smoking and survival in female breast cancer patients , 2015, Breast Cancer Research and Treatment.
[187] R. Gelber,et al. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial , 2009, Breast Cancer Research and Treatment.
[188] Lyndsay Harris,et al. Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma , 2002, Cancer.
[189] David R. Williams,et al. Understanding and Addressing Racial Disparities in Health Care , 2000, Health care financing review.